NO904551L - Quinolonforbindelser og fremgangsmaate for deres fremstilling. - Google Patents
Quinolonforbindelser og fremgangsmaate for deres fremstilling.Info
- Publication number
- NO904551L NO904551L NO90904551A NO904551A NO904551L NO 904551 L NO904551 L NO 904551L NO 90904551 A NO90904551 A NO 90904551A NO 904551 A NO904551 A NO 904551A NO 904551 L NO904551 L NO 904551L
- Authority
- NO
- Norway
- Prior art keywords
- procedures
- preparation
- represents hydrogen
- hydrogen
- carbon atoms
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 150000007660 quinolones Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001207 fluorophenyl group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019890015202A KR910009330B1 (ko) | 1989-10-23 | 1989-10-23 | 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO904551D0 NO904551D0 (no) | 1990-10-22 |
| NO904551L true NO904551L (no) | 1991-04-24 |
Family
ID=19290919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90904551A NO904551L (no) | 1989-10-23 | 1990-10-22 | Quinolonforbindelser og fremgangsmaate for deres fremstilling. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5091384A (cs) |
| EP (1) | EP0424850A1 (cs) |
| JP (1) | JPH03193780A (cs) |
| KR (1) | KR910009330B1 (cs) |
| CN (1) | CN1051176A (cs) |
| AU (1) | AU6486790A (cs) |
| CA (1) | CA2028208A1 (cs) |
| FI (1) | FI905171A7 (cs) |
| HU (1) | HUT56367A (cs) |
| IE (1) | IE903778A1 (cs) |
| IL (1) | IL96091A0 (cs) |
| IN (1) | IN171602B (cs) |
| MA (1) | MA21983A1 (cs) |
| MX (2) | MX22953A (cs) |
| NO (1) | NO904551L (cs) |
| PL (1) | PL287456A1 (cs) |
| PT (1) | PT95642A (cs) |
| YU (1) | YU198290A (cs) |
| ZA (1) | ZA908428B (cs) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252734A (en) * | 1989-04-03 | 1993-10-12 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
| DE4032560A1 (de) * | 1990-10-13 | 1992-04-16 | Bayer Ag | 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate |
| DE4121214A1 (de) * | 1991-06-27 | 1993-01-14 | Bayer Ag | 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate |
| EP0549857A1 (en) * | 1991-12-31 | 1993-07-07 | Korea Research Institute Of Chemical Technology | Antibacterial quinolone carboxylic acid derivatives |
| NO301165B1 (no) * | 1992-12-25 | 1997-09-22 | Daiichi Seiyaku Co | Bicykliske aminderivater og antibakterielle midler inneholdende disse |
| KR0148277B1 (ko) * | 1993-01-18 | 1998-11-02 | 채영복 | 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법 |
| AU4272793A (en) * | 1993-04-24 | 1994-11-21 | Korea Research Institute Of Chemical Technology | Novel quinolone carboxylic acid derivatives and process for preparing the same |
| DE4339134A1 (de) * | 1993-11-16 | 1995-05-18 | Bayer Ag | 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate |
| KR950018003A (ko) * | 1993-12-09 | 1995-07-22 | 스미스클라인 비참 피엘씨 | 신규한 퀴놀론 유도체 및 그의 제조 방법 |
| DE19652239A1 (de) | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| KR20160087900A (ko) | 2013-11-26 | 2016-07-22 | 에프. 호프만-라 로슈 아게 | 신규한 옥타하이드로-사이클로부타[1,2-c；3,4-c'']다이피롤-2-일 |
| CN110204550B (zh) | 2014-03-26 | 2022-05-17 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物 |
| WO2016046837A1 (en) * | 2014-09-22 | 2016-03-31 | Cadila Healthcare Limited | An improved process for preparation of pyrrolo[3,4- c] pyrrole compounds and intermediates thereof |
| KR20180043837A (ko) | 2015-09-04 | 2018-04-30 | 에프. 호프만-라 로슈 아게 | 페녹시메틸 유도체 |
| EP3353180B1 (en) | 2015-09-24 | 2022-03-16 | F. Hoffmann-La Roche AG | Bicyclic compounds as atx inhibitors |
| WO2017050791A1 (en) * | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual atx/ca inhibitors |
| BR112017026682A2 (pt) | 2015-09-24 | 2018-08-14 | Hoffmann La Roche | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
| EP3596060B1 (en) | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | New bicyclic compounds as atx inhibitors |
| SG11201908560SA (en) | 2017-03-16 | 2019-10-30 | Hoffmann La Roche | Heterocyclic compounds useful as dual atx/ca inhibitors |
| KR102296703B1 (ko) | 2017-03-20 | 2021-09-01 | 포르마 세라퓨틱스 인크. | 피루베이트 키나제 (pkr) 활성화제로서의 피롤로피롤 조성물 |
| CN113226356B (zh) | 2018-09-19 | 2025-03-04 | 诺沃挪第克健康护理股份公司 | 活化丙酮酸激酶r |
| US10675274B2 (en) | 2018-09-19 | 2020-06-09 | Forma Therapeutics, Inc. | Activating pyruvate kinase R |
| BR112022004376A2 (pt) | 2019-09-19 | 2022-06-07 | Forma Therapeutics Inc | Ativação de piruvato quinase r |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE55898B1 (en) * | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
| WO1989005643A1 (en) * | 1987-12-18 | 1989-06-29 | Pfizer Inc. | Heterocyclic-substituted quinoline-carboxylic acids |
| JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
| JPH0262875A (ja) * | 1988-05-23 | 1990-03-02 | Wakunaga Pharmaceut Co Ltd | 新規イソインドリン誘導体 |
-
1989
- 1989-10-23 KR KR1019890015202A patent/KR910009330B1/ko not_active Expired
-
1990
- 1990-09-19 IN IN743/MAS/90A patent/IN171602B/en unknown
- 1990-10-19 US US07/599,225 patent/US5091384A/en not_active Expired - Fee Related
- 1990-10-19 FI FI905171A patent/FI905171A7/fi not_active Application Discontinuation
- 1990-10-20 HU HU906522A patent/HUT56367A/hu unknown
- 1990-10-22 EP EP90120240A patent/EP0424850A1/en not_active Withdrawn
- 1990-10-22 MA MA22253A patent/MA21983A1/fr unknown
- 1990-10-22 CN CN90108658A patent/CN1051176A/zh active Pending
- 1990-10-22 PT PT95642A patent/PT95642A/pt not_active Application Discontinuation
- 1990-10-22 YU YU198290A patent/YU198290A/sh unknown
- 1990-10-22 JP JP2282067A patent/JPH03193780A/ja active Pending
- 1990-10-22 ZA ZA908428A patent/ZA908428B/xx unknown
- 1990-10-22 IE IE377890A patent/IE903778A1/en unknown
- 1990-10-22 MX MX2295390A patent/MX22953A/es unknown
- 1990-10-22 CA CA002028208A patent/CA2028208A1/en not_active Abandoned
- 1990-10-22 PL PL28745690A patent/PL287456A1/xx unknown
- 1990-10-22 NO NO90904551A patent/NO904551L/no unknown
- 1990-10-22 AU AU64867/90A patent/AU6486790A/en not_active Abandoned
- 1990-10-22 MX MX2295490A patent/MX22954A/es unknown
- 1990-10-23 IL IL96091A patent/IL96091A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA908428B (en) | 1992-05-27 |
| KR910007931A (ko) | 1991-05-30 |
| FI905171A7 (fi) | 1991-04-24 |
| MX22954A (es) | 1994-01-31 |
| YU198290A (sh) | 1992-09-07 |
| JPH03193780A (ja) | 1991-08-23 |
| PT95642A (pt) | 1991-09-13 |
| AU6486790A (en) | 1991-04-26 |
| IL96091A0 (en) | 1991-07-18 |
| KR910009330B1 (ko) | 1991-11-11 |
| PL287456A1 (en) | 1992-04-21 |
| HUT56367A (en) | 1991-08-28 |
| IE903778A1 (en) | 1991-04-24 |
| US5091384A (en) | 1992-02-25 |
| CA2028208A1 (en) | 1991-04-24 |
| EP0424850A1 (en) | 1991-05-02 |
| FI905171A0 (fi) | 1990-10-19 |
| MX22953A (es) | 1993-12-01 |
| MA21983A1 (fr) | 1991-07-01 |
| CN1051176A (zh) | 1991-05-08 |
| IN171602B (cs) | 1992-11-21 |
| NO904551D0 (no) | 1990-10-22 |
| HU906522D0 (en) | 1991-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO904551L (no) | Quinolonforbindelser og fremgangsmaate for deres fremstilling. | |
| NO305209B1 (no) | N-alkyl-2-substituerte ATP-analoger, slike forbindelser til fremstilling av terapeutikum, farmas°ytisk preparat inneholdende slike forbindelser, og deres anvendelse | |
| HUP0204283A2 (hu) | (Kinolil-propil)-piperidin-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| IL63613A (en) | Dihydrohalo oxo-pyrido(1,2,3-de)(1,4)benzoxazine carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| ES8201966A1 (es) | Un procedimiento de produccion de derivados de fenetilamina sulfamoil-sustituidos | |
| AU6690686A (en) | Piperdine derivative and pharmaceutical composition | |
| NO941611D0 (no) | Nye aminosyrederivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende disse forbindelser | |
| ES8601965A1 (es) | Un procedimiento para la preparacion de una nueva serie de derivados de (1-piperidinilalquil)pirimidinona | |
| NO923618L (no) | Benzanilid-derivater | |
| AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
| DK264990D0 (da) | Purinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse | |
| NO924929L (no) | Farmasoeytisk aktive benzoquinazolinforbindelser | |
| NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
| NZ503822A (en) | 2-halo-6-O-substituted erythromycin derivatives, a process for their preparation and pharmaceuticals thereof, useful for treating bacterial infections | |
| DK178488A (da) | Amino-5,6,7,8-tetrahydronaphtho(2,3-b)furanderivater, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem | |
| DK213087A (da) | 1,4-disubstituerede piperazinderivater og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| NO812355L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater | |
| DK0623138T3 (da) | Nye adenosinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf | |
| ES8800214A1 (es) | Procedimiento para preparar derivados de bencimidazol substituidos | |
| JO1629B1 (en) | Andadnodol compounds i | |
| HUT60275A (en) | Process for producing 7-acyl-3-(substituted carbamoyloxy)-cef-3-em-4-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds | |
| AU1998995A (en) | Substituted fused and bridged bicyclic compounds as therapeutic agents | |
| MY120617A (en) | Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives. | |
| HUP0204217A2 (en) | Novel a-500359 derivatives | |
| IL81337A (en) | Heptanoyl-glu-asp-ala-amino acid immunostimulants,process for their preparation and pharmaceutical compositions containing them |